JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Financials | 11.06% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Healthcare | 9.57% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Medifast
MED
$132M
| $14.8M | ﹤0.01% |
52,216
-8,833
| -14% | -$2.39M |
|
|
PR
2027
Permian Resources
PR
$17.6B
| $14.8M | ﹤0.01% |
2,177,761
+1,275,648
| +141% | +$6.59M |
|
2028
Churchill Downs
CHDN
$6.17B
| $14.8M | ﹤0.01% |
148,834
-97,732
| -40% | -$10M |
|
|
ILPT
2029
Industrial Logistics Properties Trust
ILPT
$616M
| $14.8M | ﹤0.01% |
564,361
-73,212
| -11% | -$1.84M |
|
2030
iShares Micro-Cap ETF
IWC
$1.51B
| $14.7M | ﹤0.01% |
96,610
-259
| -0.3% | -$38.4K |
|
2031
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $14.7M | ﹤0.01% |
108,032
+30,602
| +40% | +$4.14M |
|
2032
Kulicke & Soffa
KLIC
$5.01B
| $14.7M | ﹤0.01% |
240,215
+70,372
| +41% | +$3.79M |
|
2033
PUT
B&G Foods
BGS
$300M
| $14.7M | ﹤0.01% |
447,600
+434,000
| +3,191% | +$13.4M |
|
2034
PUT
Tanger
SKT
$4.47B
| $14.7M | ﹤0.01% |
778,100
-105,000
| -12% | -$1.84M |
|
2035
HNI Corp
HNI
$3.61B
| $14.7M | ﹤0.01% |
333,442
+32,562
| +11% | +$1.41M |
|
|
VRTV
2036
DELISTED
VERITIV CORPORATION
VRTV
| $14.6M | ﹤0.01% |
238,403
+13,950
| +6% | +$729K |
|
|
BBBY
2037
DELISTED
Bed Bath & Beyond Inc
BBBY
| $14.6M | ﹤0.01% |
439,634
-216,757
| -33% | -$6.03M |
|
2038
Watsco Inc
WSO
$12.9B
| $14.6M | ﹤0.01% |
50,843
-3,814
| -7% | -$1.09M |
|
|
USCR
2039
DELISTED
U S Concrete, Inc.
USCR
| $14.6M | ﹤0.01% |
197,329
+127,087
| +181% | +$8.22M |
|
2040
ICL Group
ICL
$6.98B
| $14.6M | ﹤0.01% |
2,121,166
+126,040
| +6% | +$858K |
|
2041
PUT
TG Therapeutics
TGTX
$7.47B
| $14.5M | ﹤0.01% |
+375,000
| New | +$14.7M |
|
2042
Canadian Solar
CSIQ
$1.06B
| $14.5M | ﹤0.01% |
324,283
+321,839
| +13,169% | +$13.2M |
|
2043
Amkor Technology
AMKR
$14.2B
| $14.5M | ﹤0.01% |
614,050
-1,201,985
| -66% | -$26.7M |
|
2044
Corcept Therapeutics
CORT
$12.1B
| $14.5M | ﹤0.01% |
659,783
+469,589
| +247% | +$10.4M |
|
2045
Kadant
KAI
$3.94B
| $14.5M | ﹤0.01% |
82,324
-2,005
| -2% | -$353K |
|
|
WPF
2046
DELISTED
Foley Trasimene Acquisition Corp.
WPF
| $14.4M | ﹤0.01% |
1,476,000
+1,233,248
| +508% | +$12.5M |
|
|
CSR
2047
Centerspace
CSR
$949M
| $14.4M | ﹤0.01% |
182,588
-19,287
| -10% | -$1.39M |
|
2048
Olin
OLN
$2.17B
| $14.4M | ﹤0.01% |
311,398
-180,681
| -37% | -$8.14M |
|
2049
Korro Bio
KRRO
$202M
| $14.4M | ﹤0.01% |
28,884
+28,556
| +8,706% | +$13.9M |
|
2050
iShares Latin America 40 ETF
ILF
$3.71B
| $14.4M | ﹤0.01% |
455,854
-136,918
| -23% | -$4.1M |
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.